Frequency Therapeutics Statistics
Share Statistics
Frequency Therapeutics has 36.52M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 36.52M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 909 |
| FTD / Avg. Volume | 0.67% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Frequency Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.53 |
| Debt / FCF | -0.57 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,773,478.26 |
| Employee Count | 46 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2K |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 0.13% in the
last 52 weeks. The beta is 0.77, so Frequency Therapeutics's
price volatility has been higher than the market average.
| Beta | 0.77 |
| 52-Week Price Change | 0.13% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.77 |
| Relative Strength Index (RSI) | 51.7 |
| Average Volume (20 Days) | 135,075 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -83M |
| Net Income | -81.58M |
| EBITDA | -80.62M |
| EBIT | -80.62M |
| Earnings Per Share (EPS) | -2.33 |
Full Income StatementBalance Sheet
The company has 83.1M in cash and 42.95M in
debt, giving a net cash position of 40.15M.
| Cash & Cash Equivalents | 83.1M |
| Total Debt | 42.95M |
| Net Cash | 40.15M |
| Retained Earnings | -261.67M |
| Total Assets | 46.35M |
| Working Capital | 32.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -67.28M
and capital expenditures -7.84M, giving a free cash flow of -75.12M.
| Operating Cash Flow | -67.28M |
| Capital Expenditures | -7.84M |
| Free Cash Flow | -75.12M |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
